Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR+4.1%
5Y CAGR+6.1%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+4.1%/yr
vs +28.8%/yr prior
5Y CAGR
+6.1%/yr
Consistent
Acceleration
-24.7pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $105.10M | +17.3% |
| 2024 | $89.59M | -50.4% |
| 2023 | $180.68M | +94.1% |
| 2022 | $93.09M | +2.2% |
| 2021 | $91.06M | +16.3% |
| 2020 | $78.32M | +36.7% |
| 2019 | $57.28M | +69.3% |
| 2018 | $33.83M | +48.1% |
| 2017 | $22.84M | +9.7% |
| 2016 | $20.82M | - |